Search
for
Sort by
Research 901–930 of 1000+
- Use of chemotherapy during human pregnancy
- The Chicken Frizzle Feather Is Due to an α-Keratin (KRT75) Mutation That Causes a Defective Rachis
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Wound Healing: A Cellular Perspective
- Mechanisms regulating skin immunity and inflammation
- Harmless Herbs? A Review of the Recent Literature
- Melatonin membrane receptors in peripheral tissues: Distribution and functions
- Pharmacology of anabolic steroids
- EZH1 and EZH2 cogovern histone H3K27 trimethylation and are essential for hair follicle homeostasis and wound repair
- Identification of the cell lineage at the origin of basal cell carcinoma
- Stem Cells and the Niche: A Dynamic Duo
- The Dynamics of the Skin’s Immune System
- Prospect of Stem Cell Conditioned Medium in Regenerative Medicine
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Alopecia areata
- Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review
- Severe cutaneous adverse reactions to drugs
- Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
- Coordinated Activation of Wnt in Epithelial and Melanocyte Stem Cells Initiates Pigmented Hair Regeneration
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Serotoninergic and melatoninergic systems are fully expressed in human skin
- Transforming growth factor-β in stem cells and tissue homeostasis
- <i>Hoxc13</i> mutant mice lack external hair
- Molecular mechanisms of androgenetic alopecia
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Biomaterials Functionalized with MSC Secreted Extracellular Vesicles and Soluble Factors for Tissue Regeneration
- More than one way to skin . . .
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma